Heterosubstituted pyridine derivatives as pde 4 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 213/89 (2006.01) A61K 31/4427 (2006.01) A61P 11/00 (2006.01) C07D 213/64 (2006.01) C07D 213/76 (2006.01) C07D 213/79 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2369092

The invention encompasses the novel compound of Formula (I) useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3',5'-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE 4). The invention also encompasses pharmaceutical compositions and methods for treatment.

L'invention concerne un nouveau composé représenté par la formule (I) utilisé dans le traitement de maladies, y compris l'asthme, pour augmenter le niveau d'adénosine-3',5'-monophosphate (cAMP) cyclique par l'inhibition de phosphodiestérase IV (PDE 4). L'invention concerne également des compositions pharmaceutiques et des méthodes de traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterosubstituted pyridine derivatives as pde 4 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterosubstituted pyridine derivatives as pde 4 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterosubstituted pyridine derivatives as pde 4 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1658411

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.